Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma

Bone Marrow Transplantation
F K BuadiD J Inwards

Abstract

To evaluate autologous stem cell transplant (ASCT) in older patients with intermediate grade non-Hodgkin's lymphoma (NHL), the Mayo Clinic Rochester BMT database was reviewed for all patients 60 years of age and older who received ASCT for NHL between September 1995 and February 2003. Factors evaluated included treatment-related mortality (TRM), event-free survival (EFS) and overall survival (OS). Ninety-three patients were identified, including twenty-four (26%) over the age of 70 years. Treatment-related mortality (5.4%) was not significantly different when compared to a younger cohort (2.2%). At a median follow-up of 14 months (0.6-87.6 months), the estimated median survival is 25 months (95% confidence interval (CI) 12-38) in the older group compared to 56 months (95% CI 37-75) (P=0.037) in the younger group. The estimated 4-year EFS was 38% for the older group compared to 42% in the younger cohort (P=0.1). By multivariate analysis, the only factor found to influence survival in the older group was age-adjusted International Prognostic Index at relapse, 0-1 better than 2-3 (P=0.03). Autologous stem-cell transplant can be safely performed in patients 60 years or older with chemotherapy sensitive relapsed or first partial rem...Continue Reading

References

Jan 1, 1987·British Journal of Cancer·N BarnesC C Bird
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W S VelasquezF Cabanillas
Apr 8, 1993·The New England Journal of Medicine·J O Armitage
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D ChesonG P Canellos
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N L HarrisC D Bloomfield
Mar 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I N MicallefA Z Rohatiner
May 18, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·C S LegerL Huebsch
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Feb 6, 2003·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jun 19, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jacob D BitranJosie Rowen

❮ Previous
Next ❯

Citations

Oct 17, 2006·Bone Marrow Transplantation·E Jantunen
Oct 11, 2012·Revista brasileira de hematologia e hemoterapia·Juliana Pereira
May 7, 2010·Leukemia & Lymphoma·Mathias Witzens-Harig, Peter Dreger
Aug 1, 2007·Expert Review of Pharmacoeconomics & Outcomes Research·Christopher Knight, Fiona Maciver
Jun 13, 2012·Best Practice & Research. Clinical Haematology·Peter MartinBrian Till
Apr 24, 2007·Best Practice & Research. Clinical Haematology·J G CoghlanP D Kottaridis
Sep 6, 2015·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Sinem Civriz Bozdag, Osman Ilhan
Feb 18, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ajay K GopalOliver W Press
Jul 24, 2015·Current Oncology Reports·Oscar B LahoudParastoo Bahrami Dahi
Jul 27, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Denise M OlianskyTheresa Hahn
Dec 2, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Hillard M LazarusUNKNOWN Center For International Blood & Marrow Transplant Research (CIBMTR)
Jun 11, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Tanya M WildesSteven M Devine
Feb 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ajay K GopalOliver W Press
Dec 15, 2010·Bone Marrow Transplantation·D J AndorskyL Pinter-Brown
Jan 19, 2011·Bone Marrow Transplantation·N PuigM Crump
Nov 6, 2018·Bone Marrow Transplantation·Parastoo B DahiSergio A Giralt
Jun 14, 2018·The Oncologist·Haige YeMichael L Wang
Oct 7, 2011·Cancer Control : Journal of the Moffitt Cancer Center·Ernesto Ayala, Marcie Tomblyn
Jun 20, 2012·Cancer Control : Journal of the Moffitt Cancer Center·Ernesto Ayala
Dec 17, 2014·Cancer Control : Journal of the Moffitt Cancer Center·Luciano J CostaShari J Dermer
Feb 15, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C HosingI Khouri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.